What is GHK-Cu?
Compound Spotlight
GHK-Cu began as an odd result in a liver-cell experiment and became one of the most studied small peptides in skin biology. It is three amino acids holding a single copper ion, and it occurs naturally in human blood. Most of what is known about it in people comes from skin research, not from medicine.
Quick summary
- GHK is the tripeptide glycyl-histidyl-lysine (Gly-His-Lys). GHK-Cu is that tripeptide bound to a copper(II) ion.
- Identified in human plasma by Loren Pickart and colleagues, first reported in 1973.
- In 1980 the same researchers reported that GHK circulates complexed with copper and iron and binds several transition metals, but not sodium, potassium or calcium.
- Cell work found GHK-Cu stimulated collagen synthesis in fibroblasts at very low (picomolar to nanomolar) concentrations.
- In rat wound models it increased collagen, glycosaminoglycan and total protein deposition; a control tripeptide did not.
- Human evidence is mostly topical and cosmetic. There are no large controlled trials of GHK-Cu as a medicine.
Where it comes from
In the early 1970s, Loren Pickart, working with M.M. Thaler, was studying factors in human serum that affect liver cells grown in culture. Their 1973 report in Nature New Biology described a tripeptide in human serum that prolonged the survival of normal liver cells and stimulated the growth of cells from a liver tumor. That tripeptide was later characterized as Gly-His-Lys.
The first decade of work treated GHK as a growth-modulating factor for cultured cells. Its later reputation in wound repair and skin research came from a different line of studies, beginning in the late 1980s, which is covered below.
The metal is part of the molecule
A 1980 paper by Pickart and Thaler in the Journal of Cellular Physiology reported that GHK in plasma is associated with copper and iron, and proposed that it acts as a peptide-metal complex. In the test tube, at physiological pH, GHK bound copper, cobalt, iron, nickel, zinc and other transition metals, but showed no affinity for sodium, potassium or calcium.
In those experiments, copper and iron were the most active partners. The metals on their own inhibited growth of a hepatoma cell line in low-serum conditions, while the GHK-metal combination reversed that inhibition at nanomolar concentrations. That result is the origin of the idea that GHK-Cu, not bare GHK, is the form that matters, and it is why research material is supplied as the copper complex.
Our GLOW Blend article covers the copper-carrier argument and the copper-dependent enzymes in more detail, so it is not repeated here.
From liver cells to wound repair
The turn toward connective tissue came from François-Xavier Maquart’s group in Reims, France. In 1988 they reported in FEBS Letters that GHK-Cu stimulated collagen synthesis in cultured fibroblasts. The effect began between 10-12 and 10-11 molar, peaked around 10-9 molar, and did not depend on a change in cell number.
The same paper made an observation that shaped later thinking: the Gly-His-Lys sequence occurs within the alpha-2 chain of type I collagen. The authors suggested that GHK could be released when proteases break collagen down at a wound, and then act locally to promote repair. In this picture GHK is a signal produced by tissue damage itself, a fragment of the matrix that helps rebuild the matrix.
In 1993 the group moved to animals. In a rat wound-chamber model published in the Journal of Clinical Investigation, chambers treated with GHK-Cu showed concentration-dependent increases in dry weight, DNA, total protein, collagen and glycosaminoglycans. Collagen synthesis rose about twice as much as non-collagen protein, and mRNA for type I and type III collagen increased. A control tripeptide, Glu-His-Pro, had no significant effect, which argues the result was specific to the GHK sequence rather than to any small peptide.
Gene-expression claims, read carefully
Since 2012, Pickart and colleagues have published a series of reviews drawing on gene-expression databases. A 2015 review in BioMed Research International states that GHK can up- or down-regulate at least 4,000 human genes, and the 2018 review in the International Journal of Molecular Sciences links this to reported effects ranging from tissue repair to anti-inflammatory and antioxidant activity.
Two points help in reading this literature. First, a change in the expression of thousands of genes in a database comparison does not show which of those changes, if any, produce a given effect in tissue. Second, many of the broad review articles on GHK-Cu are written by Pickart’s own group, which lists a skin-care research and development affiliation. That does not make the work wrong, but independent replication carries more weight than review volume.
What the evidence supports
The strongest mechanistic evidence comes from cell culture (fibroblast collagen synthesis, hepatoma cell growth) and from rodent wound models, where GHK-Cu increased extracellular matrix deposition and influenced matrix metalloproteinase activity. Reviews also describe wound-healing findings in other animal species.
Human data are mostly topical. The 2015 review summarizes cosmetic studies reporting changes in skin firmness, elasticity, density and fine lines with GHK-Cu-containing products. These are studies of finished cosmetic formulations, some combining GHK-Cu with other active ingredients. They tell us about topical products on skin, not about systemic exposure, and they are not drug trials.
GHK-Cu is not an approved medicine. The honest summary is a well-characterized metal-binding peptide with consistent preclinical results in matrix biology, a cosmetic literature of uneven quality, and no controlled clinical program establishing a therapeutic use.
Frequently asked questions
Is GHK-Cu the same as “copper peptide” in skincare products?
Skincare products labeled “copper peptide” frequently contain GHK-Cu, but the label alone does not say which peptide or how much. Concentration, formulation and purity vary between products, and cosmetic labeling does not carry the identity testing of research-grade material.
Why is the copper complex used rather than plain GHK?
Early work found that GHK exists in plasma bound to metal ions and that its activity in cell culture depended on that pairing, with copper among the most active. Most subsequent studies therefore used the copper complex.
Does the body make GHK naturally?
Yes. GHK was isolated from human plasma, and reviews report it in saliva and urine as well, with levels declining with age. The sequence also occurs within type I collagen, which is one proposed source.
How do I know what is actually in the vial?
Every lot we sell has a published Certificate of Analysis from an independent, third-party lab confirming identity and purity. Lot numbers on the vial should match the COA you are referencing.
References
- Pickart L, Thaler MM. Tripeptide in human serum which prolongs survival of normal liver cells and stimulates growth in neoplastic liver. Nat New Biol. 1973;243(124):85–87.
- Pickart L, Thaler MM. Growth-modulating tripeptide (glycylhistidyllysine): association with copper and iron in plasma, and stimulation of adhesiveness and growth of hepatoma cells in culture by tripeptide-metal ion complexes. J Cell Physiol. 1980;102(2):129–139.
- Maquart FX, et al. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Lett. 1988;238(2):343–346.
- Maquart FX, et al. In vivo stimulation of connective tissue accumulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+ in rat experimental wounds. J Clin Invest. 1993;92(5):2368–2376.
- Siméon A, et al. Expression and activation of matrix metalloproteinases in wounds: modulation by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. J Invest Dermatol. 1999;112(6):957–964.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. Biomed Res Int. 2015;2015:648108.
- Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. Int J Mol Sci. 2018;19(7):1987.
View the GHK-Cu product listing →
Read our GLOW Blend breakdown →
Look up your lot Certificate of Analysis →
For laboratory and research use only. Not for human consumption. GHK-Cu is not approved by any regulatory authority as a medicine, and published human data come mainly from topical cosmetic research. This article summarizes published research for informational purposes and is not medical advice, nor a recommendation or protocol for use.
Related research compounds
Arc Peptides supplies these compounds, each third-party tested for purity and identity with a lot-specific Certificate of Analysis:
For laboratory research use only. Not for human consumption.
